Catalyst Event

Sanofi (SNY) · Other

From KEDI Tesla Fixed Tech100 Index (KTSLT100)

6/5/2026, 12:00:00 AM

OtherSentiment: Neutral

Sanofi entered a five-year strategic collaboration with AI company Owkin to license its K Pro platform to accelerate the development of next-generation biopharma agents.

Korean Translation

차세대 바이오의약품 개발 가속화를 위해 AI 기업 오킨(Owkin)과 5년간 K Pro 플랫폼을 라이선스하는 전략적 협력 계약을 체결함

Related Recent Events

View Full Timeline